ClinicalTrials.Veeva

Menu

Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With CVS

S

Superior University

Status

Active, not recruiting

Conditions

Computer Vision Syndrome

Treatments

Combination Product: EXP group (Routine CVS treatment)
Diagnostic Test: Grouyp 1 (without blinking exercises).

Study type

Interventional

Funder types

Other

Identifiers

NCT06913816
MSRSW/Batch-Fall23/810

Details and patient eligibility

About

"Computer vision syndrome (CVS), refers to a range of eye and vision issues caused by extended use of computers, tablets, e-readers, and smartphones. Computer users experience visual symptoms, such as eyestrain, headaches, eye discomfort, dry eyes, double vision, and blurred vision, especially after long periods of looking at screens, whether up close or at a distance.

Full description

Individuals will be randomly assigned to either an experimental group (group A) receiving OBT with routine rehabilitation CVS management 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops or a control group (group B) receiving only routine rehabilitation, including the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops. OBT consisted of structured blinking exercises performed thrice daily for three months. Objective outcomes, including tear film parameters and visual function using subjective Computer Vision Syndrome Questionnaire (CVS-Q) shall be evaluated. The collected data will be analysed by using SPSS."

Enrollment

52 patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals aged 18-40 years who work on computers or digital devices for at least 3 to 6 hours daily.
  • Both Male and Female.
  • Individuals who could undergo a complete ocular examination.
  • Presence of symptoms consistent with digital eye strain.
  • Presented with eye complaints such as eye fatigue, burning, irritation, redness, and blurred vision due to long-term computer or digital screen use.
  • Symptoms worsened during exposure to digital screen light.

Exclusion criteria

  • Use of medications that might influence tear production or ocular surface status (e.g., antihistamines, antidepressants).
  • Diagnosed neurological or systemic conditions that impact vision or blink patterns (e.g., Parkinson's disease, multiple sclerosis).
  • Individual's with a history of ocular surface diseases such as conjunctivitis or keratitis.
  • History of any psychiatric diagnosis."

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

52 participants in 2 patient groups

Grouyp 1 (without blinking exercises).
Active Comparator group
Treatment:
Diagnostic Test: Grouyp 1 (without blinking exercises).
EXP group (Routine CVS treatment)
Experimental group
Treatment:
Combination Product: EXP group (Routine CVS treatment)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems